Lupin Categorically Denies Sell-off Talks Amid Speculation Of $1 Billion Valuation For India Business

MUMBAI - Could Lupin Ltd. be the next to sell off its India business to a multinational drug company? Sources report that Lupin is considering selling its India business for a deal valued at as much as $1 billion, and several market analysts in India say the question is not without merit